Clinical Trials

The efficacy and safety of intra-arterial administration of REX-001 to treat ischaemic ulcers in subjects with critical limb ischaemia rutherford category 5 and diabetes mellitus: A pivotal, placebo-controlled, doble-blind, parallel-group, adaptative trial

Ficha Técnica

Investigador Principal

JOSÉ GARCÍA-REVILLO GARCÍA

Promotor

REXGENERO LIMITED

ESTADO

ACTIVO

DEPARTAMENTO

Radiodiagnóstico

Código EudraCT: 2016-003980-21

Número protocolo: REX-001-005

Fecha Inicio: 2021-02-23

Fecha Fin: 2023-12-31